Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Gillor, Osnat ^a   Giladi, Itamar ^a   Riley, Margaret A ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; COLICIN; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; LARGE INTESTINE; MOUSE; NONHUMAN; ANIMAL; BIOSYNTHESIS; ESCHERICHIA COLI INFECTION; FEMALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MUS;

ANIMALS; BACTERIOCINS; COLICINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; MICE; PHENOTYPE;

EID: 70349131189     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-165     Document Type: Article

References (42)

1. Infectious Diseases. S Gorbach JG Bartlett NR Blacklow, Philadelphia: Lippincott, Williams, and Wilkins 2003
2. Enteric flora in health and disease. F Guarner, Digestion 2006 73 Suppl 1 5 12 10.1159/000089775 16498248
3. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. A Altenhoefer S Oswald U Sonnenborn C Enders J Schulze J Hacker TA Oelschlaeger, FEMS Immunol Med Microbiol 2004 40 223 229 10.1016/S0928-8244(03)00368-7 15039098 (Pubitemid 38368186)
4. Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo. L Cursino D Smajs J Smarda RM Nardi JR Nicoli E Chartone-Souza AM Nascimento, J Appl Microbiol 2006 100 821 829 10.1111/j.1365-2672.2006.02834.x 16553738
5. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. J Henker M Laass BM Blokhin YK Bolbot VG Maydannik M Elze C Wolff J Schulze, Eur J Pediatr 2007 166 311 318 10.1007/s00431-007-0419-x 17287932
6. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. DR Mack S Michail S Wei L McDougall MA Hollingsworth, Am J Physiol Gastrointest Liver Physiol 1999 276 941 950
7. Reduction of Escherichia coli O157:H7 populations in cattle by addition of colicin E7-producing E. coli to feed. GP Schamberger RL Phillips JL Jacobs F Diez-Gonzalez, Appl Environ Microbiol 2004 70 6053 6060 10.1128/AEM.70.10.6053- 6060.2004 15466550
8. Probiotic alternatives to reduce gastrointestinal infections: the poultry experience. GM Nava LR Bielke TR Callaway MP Castaneda, Anim Health Res Rev 2005 6 105 118 10.1079/AHR2005103 16164012
9. Allelopathy in spatially distributed populations. R Durrett S Levin, J Theor Biol 1997 185 165 171 10.1006/jtbi.1996.0292 9344720
10. Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. B Kerr MA Riley MW Feldman BJ Bohannan, Nature 2002 418 171 174 10.1038/nature00823 12110887
11. Native microbial colonization of Drosophila melanogaster and its use as a model of Enterococcus faecalis pathogenesis. CR Cox MS Gilmore, Infect Immun 2007 75 1565 1576 10.1128/IAI.01496-06 17220307
12. Antibiotic-mediated antagonism leads to a bacterial game of rock-paper-scissors in vivo. BC Kirkup MA Riley, Nature 2004 428 412 414 10.1038/nature02429 15042087
13. Sur un remarquable exemple d'antagonisme entre deux souches de coilbacille. A Gratia, Comp Rend Soc Biol 1925 93 1040 1041
14. Host gastro-intestinal dynamics and the frequency of colicin production by Escherichia coli. B Barnes H Sidhu DM Gordon, Microbiology 2007 153 2823 2827 10.1099/mic.0.2007/007120-0 17768227
15. Bacteriocins, spite and virulence. A Gardner SA West A Buckling, Proc R Soc Lond B Biol Sci 2004 271 1529 1535 10.1098/rspb.2004.2756 (Pubitemid 38943082)
16. Spatial polymorphism of bacteriocins and other allelopathic traits. S Frank, Evol Ecol 1994 8 369 386 10.1007/BF01238189
17. A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages. MA Riley DM Gordon, J Gen Microbiol 1992 138 1345 1352 1512564
18. Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli. DM Gordon CL O'Brien, Microbiology 2006 152 3239 3244 10.1099/mic.0.28690-0 17074895
19. Colicin biology. E Cascales SK Buchanan D Duche C Kleanthous R Lloubes K Postle M Riley S Slatin D Cavard, Microbiol Mol Biol Rev 2007 71 158 229 10.1128/MMBR.00036-06 17347522
20. Bacteriocins: evolution, ecology, and application. MA Riley JE Wertz, Annu Rev Microbiol 2002 56 117 137 10.1146/annurev.micro.56.012302.161024 12142491
21. The dual role of bacteriocins as anti- and probiotics. O Gillor A Etzion MA Riley, Appl Microbiol Biotechnol 2008 81 591 606 10.1007/s00253-008-1726-5 18853155
22. Revised Pyocin Typing Method for Pseudomonas aeruginosa. JAM Fyfe G Harris JRW Govan, J Clin Microbiol 1984 20 47 50 6430955
23. Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine. JV Newman R Kolter DC Laux PS Cohen, Microb Pathog 1994 17 301 311 10.1006/mpat.1994.1076 7723657
24. Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization. CU Rang TR Licht T Midtvedt PL Conway L Chao KA Krogfelt PS Cohen S Molin, Clin Diagn Lab Immunol 1999 6 434 436 10225851
25. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. M Alander R Satokari R Korpela M Saxelin T Vilpponen-Salmela T Mattila-Sandholm A von Wright, Appl Environ Microbiol 1999 65 351 354 9872808
26. Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. L Morelli D Zonenschain ML Callegari E Grossi F Maisano M Fusillo, Nutrition journal 2003 2 11 10.1186/1475-2891-2-11 14613507
27. Clinical applications of probiotic agents. JM Saavedra, Am J Clin Nutr 2001 73 1147S 1151S 11393193
28. Human studies with probiotics and prebiotics: clinical implications. JM Saavedra A Tschernia, Br J Nutr 2002 87 241 S246 10.1079/BJN/2002543 12088524
29. Considerations for use of probiotic bacteria to modulate human health. ME Sanders, J Nutr 2000 130 384S 390S 10721912
30. Probiotics: facts and myths. AC Senok AY Ismaeel GA Botta, Clin Microbiol Infect 2005 11 958 966 10.1111/j.1469-0691.2005.01228.x 16307549
31. Probiotics and their potential health claims. S Santosa E Farnworth PJH Jones, Nutr Rev 2006 64 265 274 10.1111/j.1753-4887.2006.tb00209.x 16808112
32. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. SI Patzer MR Baquero D Bravo F Moreno K Hantke, Microbiology 2003 149 2557 2570 10.1099/mic.0.26396-0 12949180
33. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. S Michael, Inflamm Bowel Dis 2008 14 1012 1018 10.1002/ibd.20377 18240278
34. Complete sequence of low-copy-number plasmid MccC7-H22 of probiotic Escherichia coli H22 and the prevalence of mcc genes among human E. coli. D Smajs M Strouhal P Matejkova D Cejkova L Cursino E Chartone-Souza J Smarda AM Nascimento, Plasmid 2008 59 1 10 10.1016/j.plasmid.2007.08.002 17936903
35. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. A Donnet-Hughes F Rochat P Serrant JM Aeschlimann EJ Schiffrin, J Dairy Sci 1999 82 863 869 10342225
36. Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. P Su A Henriksson H Mitchell, J Appl Microbiol 2007 103 2392 2400 10.1111/j.1365-2672.2007.03469.x 18045424
37. Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes. M Begley RD Sleator CG Gahan C Hill, Infect Immun 2005 73 894 904 10.1128/IAI.73.2.894-904.2005 15664931
38. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. VM Sheehan RD Sleator C Hill GF Fitzgerald, Microbiology 2007 153 3563 3571 10.1099/mic.0.2007/006510-0 17906153
39. Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. VM Sheehan RD Sleator GF Fitzgerald C Hill, Appl Environ Microbiol 2006 72 2170 2177 10.1128/AEM.72.3. 2170-2177.2006 16517668
40. Colicins: structures, modes of action, transfer through membranes, and evolution. V Braun H Pilsl P Gro Arch Microbiol 1994 161 199 206 10.1007/BF00248693 8161282
41. Molecular Cloning: A Laboratory Manual. J Sambrook DW Russell, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press Third 2001
42. Alternative forms of lethality in mitomycin C-induced bacteria carrying ColE1 plasmids. JL Suit M-LJ Fan JF Sabik R Labarre SE Luria, Proc Natl Acad Sci USA 1983 80 579 583 10.1073/pnas.80.2.579 6403939